Advertisement Pharmaceutical Business review - Page 729 of 5273 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
May 15, 2026

Kyowa Kirin secures FDA approval for Crysvita dosing update

Kyowa Kirin has received approval from the US Food and Drug Administration (FDA) for a dosing update to the prescribing information for Crysvita (burosumab-twza), introducing a new option for adults with X-linked hypophosphataemia (XLH).

Continue
The recombinant, fully human monoclonal IgG1 antibody targets fibroblast growth factor 23 in XLH. Credit: Michele Ursi / Shutterstock.com.
May 14, 2026

Pfizer receives EC approval for Hympavzi to treat haemophilia

The approval is based on Phase III BASIS trial data showing Hympavzi achieved a 93% reduction in bleeding rate. Credit: PaeGAG / Shutterstock.com.
May 13, 2026

UAE approves AstraZeneca’s Baxfendy for hypertension

AstraZeneca’s Baxfendy is intended for adults with hypertension. Credit: grandbrothers / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Zydus to acquire Assertio in $166m deal
  2. Isomorphic Labs receives $2.1bn for AI drug development
  3. GSK and SBP Group team up to advance bepirovirsen launch in China
  4. Partner Therapeutics secures FDA approval for Bizengri
  5. ACROBiosystems upgrades HEK293 licence solution for R&D compliance

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography